Understanding interactions between EBV and human genomic variation

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Mandage, Rajendra, 1984-
• dc.contributor.other Santpere Baró, Gabriel
• dc.contributor.other Navarro, Arcadi
• dc.contributor.other Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut
• dc.date.accessioned 2024-03-16T02:33:25Z
• dc.date.available 2024-03-16T02:33:25Z
• dc.date.issued 2018-07-13T15:53:44Z
• dc.date.issued 2018-07-26T10:00:12Z
• dc.date.issued 2018-01-12
• dc.date.modified 2024-03-15T10:57:26Z
• dc.description.abstract The EBV has been linked to multiple human disease phenotypes and has been associated with cancers and other infections. Recently single gene analysis and genome-wide analysis studies have been exploited to uncover the human genetic variants that are linked with EBV diseases. It also suggested the substantial role of individual host genetics and also provided a clue in understanding the interaction between virus and human. Furthermore, the outcome of the EBV infection is a complex phenomenon governs by the variation in the genetic architecture of the viral and human genomes and/or the interacting environmental factors. Therefore, this PhD work is mainly a large-scale effort towards the understanding of the human and EBV genetic architecture to uncover the role of genetic variation in EBV associated infections, disease susceptibility, immune recognition and invasion. Our results also provide a framework on the impact of human and EBV genetic variation and their unusual interactions that highlight the human genetic influence affecting viral load reflecting the clinical behavior of EBV in LCLs and the other side viral antigenic variation modulating immune response to sustain persistence infection. This EBV-human perturbation is essential to follow-up in the context of the susceptibility of individual populations to a specific EBV associated pathology.
• dc.description.abstract Programa de doctorat en Biomedicina
• dc.format 144 p.
• dc.format application/pdf
• dc.format application/pdf
• dc.identifier http://hdl.handle.net/10803/586328
• dc.identifier.uri http://hdl.handle.net/10230/35157
• dc.language.iso eng
• dc.publisher Universitat Pompeu Fabra
• dc.rights L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by/4.0/
• dc.rights http://creativecommons.org/licenses/by/4.0/
• dc.rights info:eu-repo/semantics/openAccess
• dc.source TDX (Tesis Doctorals en Xarxa)
• dc.subject.keyword Epstein Barr virus (EBV)
• dc.subject.keyword 1000 Genome project
• dc.subject.keyword EBV copy number
• dc.subject.keyword Genomic variation
• dc.subject.keyword Epitope
• dc.subject.keyword Antigenic variaition
• dc.subject.keyword HLA
• dc.subject.keyword 575
• dc.title Understanding interactions between EBV and human genomic variation
• dc.type info:eu-repo/semantics/doctoralThesis
• dc.type info:eu-repo/semantics/publishedVersion